EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark SMARTAG was filed as Word mark on 06/28/2013 at the European Union Intellectual Property Office.
It was registered as a trademark on 08/23/2015.
The current status of the mark is "Trademark registered".
| Trademark form | Word mark |
| File reference | 011942414 |
| Application date | June 28, 2013 |
| Publication date | August 13, 2013 |
| Entry date | August 23, 2015 |
| Expiration date | June 28, 2033 |
Trademark owner
14 Schoolhouse Road
08873 Somerset,
US
08873 Somerset,
US
Trademark representatives
De Kleetlaan 7A (4e verdieping) Pegasus Park
1831 Diegem
BE
Objection / Complaint
11/12/2013: Likelihood of confusion
Applicant
not_available
goods and services
1
Chemical, biochemical and biological reagents in the nature of or used to create or improve antibody-drug conjugates or any protein conjugated to a drug, poly nucleotide, another protein, chemical, or other functional entity used in industry and science; Chemicals for use in bioconjugation, reversible bioconjugation, irreversible bioconjugation, reversible cysteine protection, surface modification, and prodrug production; biochemicals, namely, polypeptides, polypeptides for in vivo applications, polypeptides for in vitro applications, polynucleic acids, polynucleic acids for in vivo applications, and polynucleic acids for in vitro applications; biomolecules, namely, proteins, peptides, antibodies, antibody fragments, antibody mimetic proteins, and polynucleic acids; chemical products for diagnostic use, namely, conjugates of polypeptides with small molecule drugs, imaging agents, flourocromes and radiolabels for medical applications; biochemical preparations, namely, polypeptides, polynucleic acids, and antibodies, all for use in basic research and development, medical research; biochemical preparations, namely, polypeptides, polynucleic acids, and antibodies, all for use in diagnosis and treatment of disease; diagnostic preparations for scientific or research use in connection with antibody drug conjugates
5
Pharmaceutical preparations; Pharmaceutical products for the prevention or treatment of human diseases, namely, diseases of the immune system, respiratory system, cardiovascular system, digestive system, endocrine system, lymphatic system, muscular system, skeletal system, nervous system, urinary system, integumentary system and reproductive system; chemical, biological and biochemical preparations for medical and pharmaceutical purposes, namely, antibody-drug conjugates or any protein conjugated to a drug, poly nucleotide, another protein, chemical, or other functional entity or such preparations used as linker or payload molecules therein; Pharmaceutical preparations, namely, polypeptide bioconjugates and polynucleic acid bioconjugates for use in diagnosis and treatment of disease; biological preparations, namely, polypeptide bioconjugates and polynucleic acid bioconjugates for use in diagnosis and treatment of disease; diagnostic preparations for medical purposes in connection with the diagnosis and treatment of cancer and diseases and disorders of the immune system, respiratory system, cardiovascular system, digestive system, endocrine system, lymphatic system, muscular system, skeletal system, nervous system, urinary system, integumentary system and reproductive system; antibody preparations, namely, antibody or protein bioconjugates for use in diagnosis and treatment of disease including antibody/protein-drug conjugates, antibody/protein-radiolabled conjugates and antibody/protein-imaging agent conjugates; chemical products for medical diagnostic use, namely, polypeptide bioconjugates and polynucleic acid bioconjugates for use in diagnosis and treatment of disease; biochemical preparations, namely, polypeptide bioconjugates and polynucleic acid bioconjugates for use in diagnosis and treatment of disease
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| April 30, 2024 | Change Representative, Published | ||
| June 28, 2023 | Extension, Trade mark renewed |
ID: 11011942414